Octodrine (Vaporpac) is a stimulant drug whose pharmacology was studied in a dozen animal studies from the 1940s through the 1970s. These studies found that octodrine can increase blood pressure and cardiac output in animals. The drug was previously approved for use by the FDA as an inhalant (i.e., Vaporpac and Tickle Tackle Inhaler) and in Germany as an oral agent as part of a multicomponent medication (i.e., Ambredin and Ordinal), but is no longer available.[2]

Clinical data
Other namesOttodrina; Vaporpac; Amidrine; 2-Amino-6-methylheptane; 1,5-Dimethylhexylamine; 6-Methyl-2-heptylamine; 6-Methyl-2-heptanamine[1]
Routes of
Oral, inhaled
ATC code
  • none
Legal status
Legal status
  • Not currently marketed anywhere, Sometimes sold on the grey market
CAS Number
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.008.047
Chemical and physical data
Molar mass129.24 g/mol g·mol−1
3D model (JSmol)

Octodrine has also been found as an adulterant in sports supplements.[2]

See also


  1. CID 10982 from PubChem
  2. Cohen, Pieter A.; Travis, John C.; Keizers, Peter H. J.; Deuster, Patricia; Venhuis, Bastiaan J. (8 November 2017). "Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA)". Clinical Toxicology. 56 (6): 421–426. doi:10.1080/15563650.2017.1398328.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.